5 Needs context
The swine flu vaccine caused side effects, complications, deaths, and Guillain-Barré syndrome.
"There was a problem with the swine flu vaccine where it was a problem and it caused a lot of side effects and complications and deaths and Guillain-Barré syndrome, which is paralysis. It was not a good situation, and that was in the '80s." (said at 0:11:05)
The host is correct that the US swine flu vaccination campaign was halted after surveillance detected a significant increase in cases of Guillain-Barré syndrome (GBS), a rare immune-mediated condition that causes acute flaccid paralysis and can lead to death. However, this historic event occurred in 1976 (under the Ford administration), not the 1980s. Approximately 45 million people were vaccinated before the campaign was suspended due to the excess GBS risk (estimated at roughly 1 per 100,000 vaccinees).
Vioxx was removed from the market after research by Dr. Steven Nissen at the Cleveland Clinic demonstrated an increased risk of heart attacks.
"And then there are, you know, in medicine there are cases where there have been scientists who've questioned or doctors who question things like Vioxx, which is a one of the most powerful anti-inflammatory drugs we've ever had. And and Steve Nissen at Cleveland Clinic actually, who I know very well, is an brilliant guy. And he's like, gee, it seems like there may be, you know, some connection between increased heart attacks and taking Vioxx. And so he he did the research and he showed that there was a problem and it was taken off the market" (said at 0:16:40)
Dr. Steven Nissen, alongside colleagues Debabrata Mukherjee and Eric Topol at the Cleveland Clinic, co-authored a landmark 2001 analysis in JAMA showing a significant increase in adjudicated thrombotic cardiovascular events and myocardial infarctions associated with rofecoxib (Vioxx) in the VIGOR trial (RR 2.38, 95% CI 1.39–4.00). This research raised national concern regarding the drug's cardiovascular safety. Vioxx was ultimately withdrawn from the market in September 2004 following the preliminary results of the APPROVe trial, a randomized controlled trial that confirmed a significantly increased risk of myocardial infarctions and thrombotic events after long-term use.
- supports: Risk of cardiovascular events associated with selective COX-2 inhibitors. (JAMA ) · cited 1754x in the literature
"The results from VIGOR showed that the relative risk of developing a confirmed adjudicated thrombotic cardiovascular event (myocardial infarction, unstable angina, cardiac thrombus, resuscitated cardiac arrest, sudden or unexplained death, ischemic stroke, and transient ischemic attacks) with rofecoxib treatment compared with naproxen was 2.38 (95% confidence interval, 1.39-4.00; P =.002)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention tr… (The New England journal of medicine 2005) · cited 2527x in the literature
"A total of 46 patients in the rofecoxib group had a confirmed thrombotic event during 3059 patient-years of follow-up (1.50 events per 100 patient-years), as compared with 26 patients in the placebo group during 3327 patient-years of follow-up (0.78 event per 100 patient-years); the corresponding relative risk was 1.92 (95 percent confidence interval, 1.19 to 3.11; P=0.008). The increased relative risk became apparent after 18 months of treatment; during the first 18 months, the event rates were similar in the two groups. The results primarily reflect a greater number of myocardial infarctions and ischemic cerebrovascular events in the rofecoxib group." (abstract, results, passage verified)
pubmedfull study (doi)
Measles mortality or incidence had already decreased by over 90% before the introduction of the measles vaccine in the 1960s.
"measles decreased by over 90% in 1968 when the measles vaccine came out, and it already had decreased by 90% in the population." (said at 0:37:50)
The statement conflates measles mortality with measles incidence. While measles mortality had declined significantly in the United States during the first half of the 20th century (due to improved sanitation, supportive care, and antibiotics for secondary bacterial infections), measles incidence did not decline prior to vaccination. Before the introduction of the measles vaccine in 1963, measles was nearly universal, infecting an estimated 3.5 to 4 million Americans (and approximately 95% of children by age 15) each year. The drop in measles incidence of over 90% by 1968 occurred as a direct result of nationwide immunization campaigns following the vaccine's licensure in 1963.
- context: Benefits Due to Immunization against Measles (Public Health Reports (1896-1970) 1969) · cited 48x in the literature
"Before vaccines were widely used, this disease represented a major public health problem in the United States; an estimated 4 million cases of measles, 4,000 cases of measles encephalitis, and 400 deaths occurred each year. The isolation of measles virus in 1954 (1) led to the development of effective vaccines. With the licensure of the live virus vaccine in 1963, a means of protecting susceptible persons in the population through vaccination became available... In 1968 the estimated number of measles cases was 250,000 or about 6 percent of the estimated mean for the 10yea,r period (1953 through 1962) prec,eding immunization." (abstract, results, passage verified)
openalexfull study (doi) - context: Impact of Measles in the United States (Clinical Infectious Diseases 1983) · cited 51x in the literature
"In the early decades of the 20th century, thousands of fatal measles infections were reported each year. During the 1950s an annual average of greater than 500,000 cases of measles and nearly 500 deaths due to measles were reported in the United States. Surveys indicated that 95% of the population had been infected with measles by the age of 15 years. The introduction of measles vaccine and its widespread use, which began in 1963, has had a major impact on the occurrence of measles in the United States." (abstract, results, passage verified)
openalexfull study (doi)
All major world religions officially hold that receiving vaccines is doctrinally permissible.
"As of right now, all religions technically state that you can get vaccines and there's nothing that's problematic about it." (said at 0:57:00)
Virtually all major world religious traditions (including Roman Catholicism, mainstream Protestantism, Eastern Orthodoxy, Sunni and Shia Islam, Judaism, Hinduism, and Buddhism) have official theological frameworks or rulings confirming that vaccination is permissible and often praiseworthy under doctrines prioritizing the preservation of human life. However, stating that 'all religions' state this without exception or that there is 'nothing problematic' overlooks two caveats: first, several smaller faith groups and specific denominations (such as Christian Science, Faith Assembly, and certain traditionalist Dutch Reformed communities) maintain theological objections prioritizing faith healing or divine providence over medical prophylaxis; second, specific vaccine production methods and ingredients (such as porcine gelatin or historical cell lines derived from elective abortions) have raised theological debates requiring formal religious rulings and moral dispensations by authorities (such as the Vatican and Islamic jurisprudence bodies).
- context: Religious perspectives on Vaccination: Mandatory Covid-19 vaccine for SA Churches (Pharos Journal of Theology 2021) · cited 14x in the literature
"Despite the fact that few religious groups oppose vaccination for a variety of reasons, almost all major religions in the world support vaccination as long as it complies with religious precepts for the preservation, protection, or well-being of livelihoods." (abstract, results, passage verified)
openalexfull study (doi) - context: “What is the problem with vaccines?” A typology of religious vaccine skepticism (Vaccine X 2023) · cited 24x in the literature
"The typology consists of five main types: (1) a worldview clash type, in which vaccines do not make sense as a health intervention; (2) a divine will type, which represents a form of passive fatalism; (3) an immorality type, which considers some vaccines unethical because of their production or effect; (4) an impurity type, pointing to ingredients that will defile the body; and (5) a conspiracy type, in which a vaccine plot is targeting a religious group." (abstract, results, passage verified)
openalexfull study (doi)
Mumps infection in childhood can cause male infertility or sterility.
"my stepfather had mumps when he was a kid. He was, you know, born in the '20s and ended up getting infertility and sterile because of that." (said at 1:02:37)
Mumps virus infection can cause testicular inflammation (mumps orchitis), which can lead to testicular atrophy, impaired spermatogenesis, and subfertility or infertility. However, mumps orchitis is exceedingly rare in prepubertal children and predominantly affects postpubertal adolescents and adult men (occurring in approximately 15% to 30% of postpubertal infections). Furthermore, while unilateral orchitis frequently causes temporary semen abnormalities or partial atrophy, permanent complete sterility is uncommon and typically associated only with severe bilateral orchitis.
- context: The increasing incidence of mumps orchitis: a comprehensive review. (BJU international 2010) · cited 116x in the literature
"There has been a recent increase in mumps orchitis among pubertal and postpubertal males... Unvaccinated postpubertal males diagnosed with mumps virus frequently develop complications such as mumps orchitis. Therefore, it is important that urologists are familiar with the diagnosis, treatment and complications of this condition. Here we review the epidemiology, clinical presentation, diagnostic methods, treatment options and complications of mumps orchitis, as a complication of mumps virus, with particular emphasis on testicular atrophy, subfertility and infertility." (abstract)
pubmedfull study (doi) - supports: Viral threat to male fertility. (Andrologia 2018) · cited 139x in the literature
"Certain virus types of these viruses, such as mumps virus and human immunodeficiency virus (HIV), may severely damage the testes and consequently lead to male infertility." (abstract, passage verified)
pubmedfull study (doi) - context: Mumps Orchitis: Clinical Aspects and Mechanisms. (Frontiers in immunology 2021) · cited 78x in the literature
"Mumps orchitis frequently occurs in young adult men, and leads to pain and swelling of the testis... However, a recent global outbreak of mumps and the high rate of orchitis have recently been considered as threats to male fertility." (abstract)
pubmedfull study (doi)
24 Supported by research
Aspirin is no longer recommended broadly for primary prevention of heart attacks because it increases the risk of intestinal bleeding and brain hemorrhages, and is only indicated for specific high-risk subsets.
"Recently, we used to think that aspirin was the best thing to give to everybody to prevent heart attacks, and that has completely flipped, and it's only good for a certain subset of people who are at high risk, not everybody else because it's going to cause brain hemorrhaging and intestinal bleeding." (said at 0:02:25)
Major medical guidelines, including the 2022 US Preventive Services Task Force (USPSTF) recommendation statement, recommend against broad routine use of aspirin for primary prevention of cardiovascular disease. Aspirin is no longer recommended for routine broad primary prevention in all adults, primarily because the potential reduction in cardiovascular events is balanced or offset by the risk of significant bleeding harms (such as gastrointestinal and intracranial hemorrhages). The 2022 USPSTF guidelines recommend against initiating aspirin for primary prevention in adults aged 60 years or older (D recommendation) and state that initiation in adults aged 40 to 59 years should be an individual clinical decision reserved only for those with a 10% or greater 10-year cardiovascular disease risk who are not at elevated risk for bleeding.
- supports: Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommend… (JAMA 2022) · cited 384x in the literature
"The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit. (C recommendation) The USPSTF recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults 60 years or older. (D recommendation)." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Public trust in medicine dropped from around 70% before the COVID-19 pandemic to around 40% post-pandemic.
"Trust in medicine is at the lowest it's ever been. It was 70% before the pandemic; in many studies now it's around 40%." (said at 0:07:40)
A large 50-state survey study of US adults (582,634 responses across 24 survey waves from 443,455 unique respondents) published in JAMA Network Open tracked public trust in physicians and hospitals from April 2020 to January 2024. The study found that the proportion of adults expressing 'a lot of trust' in physicians and hospitals fell significantly from 71.5% in April 2020 to 40.1% in January 2024, directly matching the claimed statistics.
Current pediatric COVID-19 vaccination rates in the US are around 10%, pediatric flu vaccination rates are around 50%, and adult COVID-19 vaccination rates are around 20%.
"Look at the COVID vaccine rates right now. I mean, you're talking like 10% for kids getting the vaccine this year with a recommendation from the CDC... If half of kids are getting flu shots and 10% are getting COVID shots and 20% of adults are getting COVID shots, then there's this distrust of the things that the CDC are recommending" (said at 0:08:50)
The speaker's estimates are supported by US Centers for Disease Control and Prevention (CDC) National Immunization Survey surveillance data for the 2023–2024 respiratory virus season. National data showed that adult coverage for the updated 2023–2024 COVID-19 vaccine was approximately 18–22% (close to 20%), pediatric COVID-19 vaccination coverage remained low at roughly 10–14%, and pediatric seasonal influenza vaccination coverage was approximately 50–54%.
The US federal government has paid out over 5 billion dollars through the National Vaccine Injury Compensation Program for vaccine injuries.
"And there's, more importantly, there's been 5 billion dollars of federal money that's been spent to pay people who've been injured by vaccines." (said at 0:11:55)
The statement is supported by published literature evaluating National Vaccine Injury Compensation Program (VICP) claims data. Established by the National Childhood Vaccine Injury Act of 1986 as a no-fault alternative to traditional tort litigation, the program has paid cumulative compensation exceeding $5 billion (and in more recent evaluations, exceeding $6 billion) since its implementation in 1988 for claims alleging vaccine-related injury or death, as well as associated legal costs.
The original whole-cell DTP vaccine was taken off the market because of potential encephalitis and neurological complications.
"We took the original DTP off the market because it could theoretically cause a lot of encephalitis and neurologic issues." (said at 0:17:35)
The original whole-cell pertussis-containing DTP vaccine (DTwP) was phased out and replaced by acellular pertussis vaccines (DTaP) in the United States and several other developed nations during the 1990s primarily due to high reactogenicity and intense public and clinical concerns regarding acute neurological adverse events, including seizures and alleged vaccine-induced encephalopathy. Although extensive subsequent epidemiological studies demonstrated that whole-cell DTP did not carry a significant causal risk of permanent brain damage or chronic encephalopathy, the drive to eliminate potential and perceived neurological risks and reduce acute side effects led directly to the adoption of acellular alternatives.
A rotavirus vaccine was removed from the market because it caused intussusception.
"We took a rotavirus vaccine off the market because it was causing intussusception." (said at 0:17:45)
In 1998, the first licensed rotavirus vaccine in the United States, RotaShield (a rhesus rotavirus tetravalent vaccine, RRV-TV), was approved for infants. In 1999, post-licensure surveillance identified an increased risk of intussusception (a serious form of bowel obstruction), particularly within 1 to 2 weeks following the first dose. Consequently, the Advisory Committee on Immunization Practices (ACIP) withdrew its recommendation and the manufacturer voluntarily withdrew the vaccine from the market.
- supports: Withdrawal of rotavirus vaccine recommendation. (MMWR. Morbidity and mortality weekly report 1999) · cited 301x in the literature
"This action was based on reports to the Vaccine Adverse Event Reporting System of intussusception (a type of bowel obstruction that occurs when the bowel folds in on itself) among 15 infants who received rotavirus vaccine. Also at that time, the manufacturer, in consultation with the Food and Drug Administration, voluntarily ceased further distribution of the vaccine." (abstract, passage verified)
pubmed - supports: A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: deve… (Novartis Foundation symposium 2001) · cited 71x in the literature
"In July 1999, after about 1.5 million doses had been given, the CDC recommended suspending administration of the vaccine because post-licensure surveillance of adverse events had suggested an association with intussusception. After further investigation by CDC, in October 1999, the ACIP withdrew its recommendation concluding that '...intussusception occurs with significantly increased frequency in the first 1-2 weeks after vaccination with RRV-TV, particularly following the first dose'." (abstract, passage verified)
pubmedfull study (doi)
The original Prevnar pneumococcal vaccine clinical trial used a meningitis vaccine as a control instead of a saline placebo.
"Like the Prevnar vaccine, the original study, there were no other Prevnars on the market. They studied against the meningitis vaccine. That makes no sense. They could have studied against saline solution water, but they studied it against meningitis." (said at 0:22:35)
The pivotal pre-licensure randomized controlled trial for the original 7-valent pneumococcal conjugate vaccine (Prevnar / PCV7), conducted through Northern California Kaiser Permanente and published in 2000, used an investigational meningococcal serogroup C conjugate vaccine (meningococcus type C CRM197 conjugate) as the active control rather than an inert saline placebo.
Dr. Paul Offit has stated that infants have the theoretical immune capacity to respond safely to 10,000 vaccines at once.
"Paul Offit's information—and and I love Paul Offit's book. I think he's a really bright guy. He says things like, 'Oh, you could have 10,000 vaccines. You have as many antigens as you want.'" (said at 0:26:40)
In a 2002 review published in Pediatrics, Dr. Paul A. Offit and colleagues examined the theoretical capacity of an infant's immune system. Using immunological estimates of circulating B cells and the diversity of antibodies they produce, the authors calculated that an infant possesses the theoretical capacity to respond to approximately 10,000 vaccines at any one time.
- supports: Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune… (Pediatrics 2002) · cited 312x in the literature
"In this review, we will examine the following: 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines; 2) the theoretic capacity of an infant's immune system; 3) data that demonstrate that mild or moderate illness does not interfere with an infant's ability to generate protective immune responses to vaccines; 4) how infants respond to vaccines given in combination compared with the same vaccines given separately; 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children; and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago." (abstract, results, passage verified)
pubmedfull study (doi)
Peptic ulcers are caused by a bacterial infection (Helicobacter pylori) rather than stress, a discovery that was awarded the Nobel Prize.
"We used to think that ulcers were caused by stress and not by a bacteria which we now know, and the guy who figured this out won the Nobel Prize and was laughed at for making this hypothesis that a bacteria would cause ulcers." (said at 0:02:09)
The speaker's statement is historically and medically accurate. Prior to the 1980s, peptic ulcer disease was widely believed to be caused primarily by stress and excess gastric acid ('no acid, no ulcer'). In 1982–1983, Australian researchers Barry Marshall and Robin Warren identified Helicobacter pylori and hypothesized that it was the primary cause of gastritis and peptic ulcers. Their hypothesis was initially met with substantial skepticism and resistance by the medical establishment. To demonstrate causation, Marshall famously ingested a culture of H. pylori, developing acute gastritis. The causal link was subsequently established in extensive clinical trials showing that eradication of the bacterium cures peptic ulcer disease. In 2005, Barry Marshall and J. Robin Warren were awarded the Nobel Prize in Physiology or Medicine for their discovery.
- supports: Helicobacter connections. (ChemMedChem 2006) · cited 44x in the literature
"The hypothesis that peptic ulcer was caused by a bacterial infection was not accepted without a fight. Most experts believed that Helicobacter was a harmless commensal, infecting people who had ulcers for some other reason. In response, Marshall drank a culture of Helicobacter to prove that the bacteria could infect a healthy person and cause gastritis." (abstract, passage verified)
pubmedfull study (doi) - supports: Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. (Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2006) · cited 37x in the literature
"The discovery of spiral bacteria in the stomach in 1983 by B.J. Marshall and R.J. Warren, Australian, clinical researches, awarded in 2005 the Nobel Prize for the third time in gastrology, has been widely considered as a major breakthrough in pathophysiology of gastritis and peptic ulcer, which for the first time can be definitively cured by merely eradication of germ infecting stomach." (abstract, passage verified)
pubmed - supports: Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transfor… (Digestive diseases (Basel, Switzerland) 2024) · cited 16x in the literature
"H. pylori emerged as cause of chronic gastritis and principal cause of peptic ulcer disease (PUD). Eradication of H. pylori became standard of care in management in PUD. The importance of this was highlighted in 2005 with the Nobel Prize in Medicine awarded to Barry Marshall and Robin Warren." (abstract, results, passage verified)
pubmedfull study (doi)
Autism was historically believed in medical consensus to be caused by emotionally distant parenting, known as 'refrigerator mothers.'
"we used to think that autism was caused by refrigerator mothers." (said at 0:02:06)
Historical medical literature documents that in post-World War II psychiatry and psychoanalysis, autism was widely conceptualized as a psychogenic condition caused by emotional frigidity or detachment in parents, commonly termed the 'refrigerator mother' hypothesis (popularized by psychoanalysts such as Bruno Bettelheim and early writings associated with Leo Kanner). This view prevailed until the late 1960s and 1970s, after which empirical neurodevelopmental and genetic evidence overturned psychogenic theories in favor of biological etiology.
Around the year 2000, thimerosal was removed from most childhood vaccines in the United States, remaining primarily in multi-dose influenza vaccines and select others.
"And then quietly around 2000, they took it out of most vaccines except the multi-dose flu vaccine and a few other vaccines. So, it's still out there." (said at 0:28:38)
In July 1999, the American Academy of Pediatrics and the U.S. Public Health Service recommended removing thimerosal from childhood vaccines as a precautionary measure to reduce infant mercury exposure. By 2001, thimerosal was removed or reduced to trace amounts in all routinely recommended childhood vaccines in the United States, with the primary exception being multi-dose vials of inactivated influenza vaccines and select other multi-dose formulations.
Mayo Clinic leads the field of vaccinomics, studying how genetic and immune differences affect individual responses to vaccines.
"there's a whole field of vaccinomics, which is at Mayo Clinic they're leading this field where they're looking at how different people respond to vaccines" (said at 0:30:31)
Vaccinomics is well established in the scientific literature as the integration of genomics, transcriptomics, proteomics, and systems biology to study how individual genetic and immunological differences govern heterogeneous responses to vaccines, with the goal of developing personalized vaccination strategies.
- supports: Towards personalized vaccines. (Frontiers in immunology 2024) · cited 29x in the literature
"The emergence of vaccinomics and system vaccinology represents a transformative shift in immunization strategies, advocating for personalized vaccines tailored to individual genetic and immunological profiles. Integrating insights from genomics, transcriptomics, proteomics, and immunology, personalized vaccines offer the promise of enhanced efficacy and safety, revolutionizing the field of vaccinology." (abstract, passage verified)
pubmedfull study (doi) - supports: Vaccine trends: a narrative review. (Journal of Yeungnam medical science 2025)
"These advances support personalized vaccine strategies, such as vaccinomics, and extend their application to noncommunicable diseases, including cancer and Alzheimer disease." (abstract, passage verified)
pubmedfull study (doi)
The original Salk polio field trial included approximately 2 million people.
"it was like 2 million people in that in that original polio study because people were really invested." (said at 0:35:43)
The 1954 Salk poliomyelitis vaccine field trial, directed by Dr. Thomas Francis Jr., was the largest clinical field trial in history, involving approximately 1.8 million schoolchildren across the United States, Canada, and Finland (consisting of vaccinated children, placebo controls, and observed non-injected controls). Describing the trial as including approximately 2 million participants is an accurate approximation of the historical trial cohort.
Vaccine developer Stanley Plotkin used human aborted fetal cell lines when developing vaccines such as the rubella vaccine.
"Stanley Plotkin's one of the founders of vaccines, you know, brilliant guy, one of the founders of the rubella vaccine... it's just really interesting to hear him discuss the use of aborted fetal tissue back when they were doing the research and how they were doing the research many years ago and how many fetuses they were using" (said at 0:56:20)
Stanley Plotkin developed the RA 27/3 rubella vaccine strain, which was isolated from an aborted fetus infected with rubella and attenuated by serial passage in WI-38 human diploid fibroblast cells, a cell strain originally derived from tissue of an aborted fetus. The RA 27/3 strain grown in WI-38 cells went on to become the standard rubella vaccine strain used worldwide, including in MMR vaccines.
Gelatin used as a stabilizer in some vaccines is derived from pigs.
"or maybe they're vegan and they don't want to inject something that has pork products in there, which gelatin does. I mean, they're taken from pigs. So, some of the vaccines have that in there." (said at 0:57:25)
The claim is supported by established pharmaceutical and clinical data. Porcine gelatin (gelatin derived from pigs) is used as a stabilizer in several live-attenuated viral vaccines, such as certain varicella (chickenpox), MMR (measles, mumps, rubella), and nasal influenza vaccines, to maintain potency during storage and freeze-drying. Recombinant human and non-animal gelatins have been tested as potential replacements, but porcine gelatin remains a common pharmaceutical excipient.
Genetic testing can identify individual susceptibility to statin-induced myopathy and muscle damage.
"So if someone, you know, has a lipid issue and I want to prescribe a statin, which I don't do that often, but if I do, I'll check their genetics. Are they going to get statin myopathy? Are they going to get muscle damage from statin?" (said at 0:31:56)
Genetic testing can identify individuals at elevated risk for statin-induced myopathy and statin-associated musculoskeletal symptoms (SAMS). Well-established pharmacogenetic variants—particularly in the SLCO1B1 hepatic transporter gene (such as rs4149056), as well as ABCG2 and CYP2C9—significantly alter systemic drug exposure, thereby increasing the risk of muscle toxicity. Clinical practice guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC) provide validated recommendations to adjust statin selection and dosing based on these genetic test results.
- supports: The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvasta… (Clinical pharmacology and therapeutics 2014) · cited 441x in the literature
"A single coding single-nucleotide polymorphism, rs4149056T>C, in SLCO1B1 increases systemic exposure to simvastatin and the risk of muscle toxicity. We summarize evidence from the literature supporting this association and provide therapeutic recommendations for simvastatin based on SLCO1B1 genotype." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and … (Clinical pharmacology and therapeutics 2022) · cited 346x in the literature
"There are several identified pharmacogenetic variants that impact statin disposition and adverse events during statin therapy. SLCO1B1 encodes a transporter (SLCO1B1; alternative names include OATP1B1 or OATP-C) that facilitates the hepatic uptake of all statins. ABCG2 encodes an efflux transporter (BCRP) that modulates the absorption and disposition of rosuvastatin. CYP2C9 encodes a phase I drug metabolizing enzyme responsible for the oxidation of some statins. Genetic variation in each of these genes alters systemic exposure to statins (i.e., simvastatin, rosuvastatin, pravastatin, pitavastatin, atorvastatin, fluvastatin, lovastatin), which can increase the risk for SAMS." (abstract, results, passage verified)
pubmedfull study (doi)
Studies measuring lead levels in children's teeth found associations between lead exposure and severe behavioral issues, aggression, and ADHD.
"We learned from Phil Landrigan and others that lead, which was measured in kids' teeth, was causing severe behavioral issues, aggression, violence, ADD, and so they made the conclusion, "Gee, lead's bad. Let's get lead out of gasoline. Let's get lead out of paint."" (said at 0:50:54)
Landmark epidemiological studies measuring lead concentrations in children's shed deciduous teeth (dentin lead) and bones demonstrated significant dose-dependent associations between low-level lead exposure and deficits in attention, impaired executive function, and behavioral issues. In a seminal 1979 study of 2,146 school children by Needleman et al., elevated dentin lead levels were strongly correlated with higher rates of non-adaptive classroom behaviors and attentional deficits on formal testing after adjusting for confounding variables. Subsequent longitudinal and cross-sectional studies further linked cumulative childhood lead burdens to attention problems, aggression, and delinquent behavior.
- supports: Deficits in psychologic and classroom performance of children with elevated dentine lead l… (The New England journal of medicine 1979) · cited 1585x in the literature
"Also evaluated by a teachers' questionnaire was the classroom behavior of all children (2146 in number) whose teeth were analyzed. The frequency of non-adaptive classroom behavior increased in a dose-related fashion to dentine lead level. Lead exposure, at doses below those producing symptoms severe enough to be diagnosed clinically, appears to be associated with neuropsychologic deficits that may interfere with classroom performance." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Attentional correlates of dentin and bone lead levels in adolescents. (Archives of environmental health 1994) · cited 179x in the literature
"Dentin lead levels were related inversely to scores on two of four attention factors: focus-execute (ability to select and respond to critical information) and shift (ability to shift focus adaptively)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Bone lead levels and delinquent behavior. (JAMA 1996) · cited 602x in the literature
"Teachers reported significant associations of lead with somatic complaints, anxious/depressed behavior, social problems, attention problems, and delinquent, aggressive, internalizing, and externalizing behavior... High bone lead levels were associated with an increased risk of exceeding the clinical score (T > 70) for attention, aggression, and delinquency." (abstract, results, passage verified)
pubmed
Many international vaccination schedules do not require hepatitis B, hepatitis A, or varicella vaccines, schedule the MMR vaccine later, and administer the meningococcal vaccine earlier compared to the United States.
"A lot of countries don't require Hep B or Hep A. A lot of countries don't require chickenpox. A lot of countries have measles, the MMR vaccine, on different schedules. So a lot of them do it later. And actually, our country is one of the few that doesn't do the meningitis shot early. A lot of countries actually do the meningitis shot earlier, the meningococcus." (said at 1:05:55)
Comparative analyses of pediatric immunization schedules between the United States and European countries confirm substantial variation across national schedules. While certain core vaccines are universally recommended, many countries do not routinely include or require vaccines such as hepatitis A, hepatitis B, or varicella (chickenpox) on their general schedules. In addition, national schedules vary regarding the timing and selection of vaccines: several European countries administer meningococcal vaccines in infancy or early childhood (such as MenB or MenC in the first year of life, compared to routine initiation at age 11–12 in the US), and notable differences exist in the scheduling and mandates for MMR and hepatitis B.
- supports: Characterizing the landscape of pediatric immunization schedules in the US and Europe. (European journal of pediatrics 2025) · cited 2x in the literature
"83.3% (20/24) of vaccines identified were included within at least one country's general pediatric vaccine schedule. Of these, 9 (45%) were recommended by all 32 countries. The total number of vaccines on countries' schedules ranged from 11 to 18. Twelve of 32 (37.5%) countries' schedules included at least one mandatory vaccination, with mandate frequency ranging from 7.1% to 93.8%... For most shots, there was general agreement about the age of the first recommended dose. However, numerical differences were noted for the meningococcal, Hepatitis B, and coronavirus disease 2019 (COVID-19) vaccines." (abstract, results, passage verified)
pubmedfull study (doi)
The United States stopped using the live oral polio vaccine because it caused more cases of polio than wild poliovirus, which has not caused a case in the US for a long time.
"Well, we don't do the live one anymore just because we realized that we're causing more polio with the live virus that you actually have and we haven't had a case in a very long time from wild polio." (said at 1:07:30)
The claim is supported by epidemiological surveillance data and national immunization policy records. Indigenous wild poliovirus was eliminated in the United States in 1979 (with the last imported wild polio case occurring in 1993). In contrast, the live oral poliovirus vaccine (OPV) caused an average of 8 to 9 cases of vaccine-associated paralytic poliomyelitis (VAPP) per year. Because the risk of VAPP exceeded the risk of acquiring wild poliovirus in the United States, the US transitioned in 1997 to a sequential IPV-OPV schedule and in 2000 adopted an exclusive inactivated poliovirus vaccine (IPV) schedule, effectively eliminating VAPP.
- supports: Vaccine policy changes and epidemiology of poliomyelitis in the United States. (JAMA 2004) · cited 205x in the literature
"The last case of poliomyelitis in the United States due to indigenously acquired wild poliovirus occurred in 1979; however, as a consequence of oral poliovirus vaccine (OPV) use that began in 1961, an average of 9 cases of vaccine-associated paralytic poliomyelitis (VAPP) were confirmed each year from 1961 through 1989. To reduce the VAPP burden, national vaccination policy changed in 1997 from reliance on OPV to options for a sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. In 2000, an exclusive IPV schedule was adopted." (abstract, context, passage verified)
pubmedfull study (doi)
Pneumococcus infection can cause meningitis and pneumonia.
"Pneumococcus can cause meningitis and pneumonia." (said at 1:08:10)
Streptococcus pneumoniae (pneumococcus) is a well-established bacterial pathogen known to cause both invasive and non-invasive infections, prominently including pneumonia and bacterial meningitis, as well as otitis media, sinusitis, and bacteremia.
- supports: Clinical manifestations, serotype distribution, and incidence of pediatric invasive pneumo… (European journal of pediatrics 2025) · cited 3x in the literature
"The most common diagnoses were pneumonia (61.8%), meningitis (14.5%), and bacteremia without focus (13.2%)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Clinical progress note: Pneumococcal disease. (Journal of hospital medicine 2025)
"With over 100 serotypes, it can cause a wide spectrum of illness ranging from acute otitis media and sinusitis to life-threatening manifestations such as bacteremia, pneumonia, and meningitis." (abstract, passage verified)
pubmedfull study (doi)
Published scientific studies indicate that delaying certain childhood vaccines decreases the risk of asthma and eczema.
"There certainly are some studies that say if you delay certain vaccines, then you decrease risk of asthma, you decrease risk of eczema. I mean, these studies exist. They're not the majority, but they're out there. And there are some actually very good studies and good journals that show this." (said at 1:10:20)
Published observational studies have reported associations between delayed childhood vaccination and a reduced risk of developing asthma. For example, a retrospective longitudinal cohort study of 11,531 children published in The Journal of Allergy and Clinical Immunology found that delaying the first dose of the whole-cell diphtheria, pertussis, and tetanus (DPT) vaccine by more than two months was associated with a roughly 50% reduction in the odds of childhood asthma by age seven, with a greater reduction observed when all three initial doses were delayed. Because these findings stem from observational retrospective cohort data rather than prospective randomized trials, they demonstrate an association rather than proven causality.
Studies show that between 5% and 10% of doctors do not fully believe that vaccines are safe.
"Even doctors, there's some studies that show that 5 to 10% of doctors don't fully believe that vaccines are safe anymore." (said at 1:14:45)
A national survey of primary care physicians in the United States published in 2022 (Callaghan et al.) evaluated vaccine confidence among physicians. The study found that 10.1% of surveyed primary care physicians did not agree that, in general, vaccines are safe, 9.3% did not agree they are effective, and 8.3% did not agree they are important. This directly supports the speaker's claim.
There is no scientific research demonstrating that an alternative or slower spaced-out vaccine schedule reduces the risk of adverse events or reactions compared to the standard schedule.
"there's no research to show that if you do a slower schedule or you do one at a time, it's going to decrease your risk." (said at 1:09:02)
The claim that there is no scientific research demonstrating that an alternative or slower spaced-out vaccine schedule reduces the risk of adverse events compared to the standard schedule is supported by published literature and consensus reports. In 2013, the Institute of Medicine (IOM) evaluated the safety of the childhood immunization schedule and concluded that available scientific evidence strongly supported the safety of the recommended schedule, finding no evidence that alternative or spaced-out schedules reduce adverse events or improve health outcomes. Subsequently, a CDC-commissioned White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink (VSD) noted that while parents delay or space out vaccines citing safety concerns, existing observational evidence supports the recommended schedule's safety, and alternative schedules lack scientific evidence demonstrating superior safety or reduced risk of adverse outcomes.
No published record matching claims of safety advantages for alternative or spaced-out vaccine schedules over the standard CDC/AAP schedule was located.
- supports: The problem with Dr Bob's alternative vaccine schedule. (Pediatrics 2009) · cited 93x in the literature
"Pediatricians now confront many parents who insist that their children receive vaccines according to Sears' schedule, rather than that recommended by the American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the American Academy of Family Physicians. This article examines the reasons for the popularity of Sears' book, deconstructs the logic and rationale behind its recommendations, and describes how Sears' misrepresentation of vaccine science misinforms parents trying to make the right decisions for their children." (abstract, passage verified)
pubmedfull study (doi) - supports: White Paper on studying the safety of the childhood immunization schedule in the Vaccine S… (Vaccine 2016) · cited 42x in the literature
"In response to public concern, the U.S. Institute of Medicine (IOM) evaluated existing research regarding the safety of the recommended immunization schedule. The IOM concluded that although available evidence strongly supported the safety of the currently recommended schedule as a whole, additional observational research was warranted to compare health outcomes between fully vaccinated children and those on a delayed or alternative schedule." (abstract, passage verified)
pubmedfull study (doi)
Rotavirus infection causes severe diarrhea in pediatric patients.
"Rotavirus gives you bad diarrhea. GUEST1: Bad diarrhea." (said at 1:08:08)
The claim is supported by high-certainty evidence. Rotavirus is well-established as a leading cause of severe acute gastroenteritis and dehydrating diarrhea in infants and young children globally.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.